The U.S. Food and Drug Administration late Monday authorized use of the drug bamlanivimab that appears to protect infected people from getting very sick.
FDA gives emergency authorization to drug that can keep COVID-19 patients out of the hospital
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push